Heparin Sodium Injection · #9 of 35 active shortages by FDA posting duration
Brand: HEPARIN SODIUM IN SODIUM CHLORIDE
FDA lists Heparin Sodium Injection as Active Shortage (Baxter Healthcare).
Availability on file: Limited Availability
Heparin Sodium Injection: Active Shortage
Limited Availability 10 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Heparin Sodium Injection
- Manufacturer
- Baxter Healthcare
- Dosage Form
- Injection
- Presentation
- Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04)
- Package NDC
- 0338-0433-04
Status & Timeline
- Status
- Active Shortage
- Availability
- Limited Availability
- First Reported
- Nov 14, 2017
- Last Updated
- Mar 4, 2026
- Therapeutic Category
- Hematology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Estimated recovery: April 2026
Full Drug Profile
heparin
Side effects, interactions, warnings & more
Nearby, Other Heparin Shortage Records
Heparin Sodium Injection
Fresenius Kabi USA, LLC
Injection
Heparin Sodium Injection
Hospira, Inc., a Pfizer Company
Injection
Heparin Sodium Injection
Hospira, Inc., a Pfizer Company
Injection
Heparin Sodium Injection
Baxter Healthcare
Injection
Heparin Sodium Injection
Baxter Healthcare
Injection
Heparin Sodium Injection
B. Braun Medical Inc.
Injection
FDA reason on file: Estimated recovery: April 2026. General shortage guidance lives on the tracker hub.